Home › Forums › Infexion Connexion › USA FDA requests postmarket studies on positive displacement needleless connector risks
- This topic has 0 replies, 1 voice, and was last updated 14 years, 4 months ago by Wishart, Michael.
-
AuthorPosts
-
04/08/2010 at 7:09 am #68387Wishart, MichaelParticipant
Author:
Wishart, MichaelEmail:
WishartM@ramsayhealth.com.auOrganisation:
State:
The US FDA has sent an open letter to US ICP’s about the possible risk
of bacteraemia in patients with positive displacement needleless
connectors. They have also requested further postmarket studies by some
specific manufacturers to ascertain the level of risk as compared to
other needleless technologies.‘Because there is presently insufficient information to determine if
positive displacement connectors increase the risk of BSI compared with
other needleless connectors, FDA is requiring the companies to conduct
postmarket surveillance studies to provide an assessment of the risk
associated with positive displacement needleless connectors.’They have not currently advised any changes in practices or use of
positive displacement needleless connectors, but that current SHEA/IDSA
recommendations should be followed.http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm220459.htm
Definitely worth keeping an eye on!
Cheers
MichaelMichael Wishart | GPH – Infection Control Coordinator
GPH – Quality & Safety Unit (Infection Control) | Greenslopes Private
Hospital
Newdegate Street, Greenslopes QLD 4120
t: 07 3394 7919 | f: 07 3394 7985
e: WishartM@ramsayhealth.com.au | w: http://www.ramsayhealth.com.auRamsay Health Care is an environmentally responsible corporation, please
consider the environment before printing this email.This e-mail message and any accompanying files may contain
information that is confidential and subject to privilege. If you
are not the intended recipient, and have received the e-mail
in error, you are notified that any use, dissemination,
distribution, forwarding, printing or copying of the message
and any attached files is strictly prohibited. If you have
received this e-mail message in error please immediately
advise the sender by return e-mail, or telephone 1800 243 903.
You must destroy the original transmission and its contents.
Any views expressed within this communication are those of
the individual sender, except where the sender specifically
states them to be the views of Ramsay Health Care.
This communication should not be copied or disseminated
without permission.
————————————————————————Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of AICA.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.